Pain Physicians Push for Abuse-Deterrent Formulation of Morphine
Pain Physicians Push for Abuse-Deterrent Formulation of Morphine
Las Vegas—The 2010 market withdrawal of an abuse-deterrent morphine product and the January 2013 FDA draft guidance on the evaluation and labeling of abuse-deterrent opioids point to the need for a new abuse-deterrent formulation (ADF) of extended …
Read more on Pain Medicine News
US judge set to rule on drug firm's suit against Massachusetts for painkiller ban
Patrick's move is an aggressive, if novel, effort to slow the toll caused by widespread abuse of opioids, which include prescription medications such as OxyContin and illegal substances such as heroin. … In a brief interview, FDA Commissioner …
Read more on Washington Post